BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 26307641)

  • 1. Impact of Fertility Concerns on Tamoxifen Initiation and Persistence.
    Llarena NC; Estevez SL; Tucker SL; Jeruss JS
    J Natl Cancer Inst; 2015 Oct; 107(10):. PubMed ID: 26307641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New Insights Into Nonadherence With Adjuvant Endocrine Therapy Among Young Women With Breast Cancer.
    Rosenberg SM; Partridge AH
    J Natl Cancer Inst; 2015 Oct; 107(10):. PubMed ID: 26307642
    [No Abstract]   [Full Text] [Related]  

  • 3. Caring for the breast cancer survivor.
    Abdel-Razeq H
    Am J Med; 2011 Feb; 124(2):e11; author reply e13. PubMed ID: 21295181
    [No Abstract]   [Full Text] [Related]  

  • 4. Adjuvant tamoxifen reduces subsequent breast cancer in women with estrogen receptor-positive ductal carcinoma in situ: a study based on NSABP protocol B-24.
    Allred DC; Anderson SJ; Paik S; Wickerham DL; Nagtegaal ID; Swain SM; Mamounas EP; Julian TB; Geyer CE; Costantino JP; Land SR; Wolmark N
    J Clin Oncol; 2012 Apr; 30(12):1268-73. PubMed ID: 22393101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient and provider factors associated with the noninitiation of tamoxifen for young women at high-risk for the development of breast cancer.
    Kandagatla P; Rizk NN; Dokic D; Kochkodan J; Estevez S; Yanik M; Goranta S; Huber-Keener K; Jeruss JS
    Breast J; 2020 Mar; 26(3):464-468. PubMed ID: 31538708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tamoxifen treatment for breast cancer and risk of endometrial cancer: a case-control study.
    Swerdlow AJ; Jones ME;
    J Natl Cancer Inst; 2005 Mar; 97(5):375-84. PubMed ID: 15741574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factor V Leiden mutation and thromboembolism risk in women receiving adjuvant tamoxifen for breast cancer.
    Garber JE; Halabi S; Tolaney SM; Kaplan E; Archer L; Atkins JN; Edge S; Shapiro CL; Dressler L; Paskett ED; Kimmick G; Orcutt J; Scalzo A; Winer E; Levine E; Shahab N; Berliner N;
    J Natl Cancer Inst; 2010 Jul; 102(13):942-9. PubMed ID: 20554945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tamoxifen Initiation After Ductal Carcinoma In Situ.
    Nichols HB; Bowles EJ; Islam J; Madziwa L; Stürmer T; Tran DT; Buist DS
    Oncologist; 2016 Feb; 21(2):134-40. PubMed ID: 26768485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Symptoms and QOL as Predictors of Chemoprevention Adherence in NRG Oncology/NSABP Trial P-1.
    Land SR; Walcott FL; Liu Q; Wickerham DL; Costantino JP; Ganz PA
    J Natl Cancer Inst; 2016 Apr; 108(4):. PubMed ID: 26615179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contralateral breast cancer and thromboembolic events in African American women treated with tamoxifen.
    McCaskill-Stevens W; Wilson J; Bryant J; Mamounas E; Garvey L; James J; Cronin W; Wickerham DL
    J Natl Cancer Inst; 2004 Dec; 96(23):1762-9. PubMed ID: 15572758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Twenty-year follow-up of the Royal Marsden randomized, double-blinded tamoxifen breast cancer prevention trial.
    Powles TJ; Ashley S; Tidy A; Smith IE; Dowsett M
    J Natl Cancer Inst; 2007 Feb; 99(4):283-90. PubMed ID: 17312305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized Placebo Controlled Trial of Low-Dose Tamoxifen to Prevent Local and Contralateral Recurrence in Breast Intraepithelial Neoplasia.
    DeCensi A; Puntoni M; Guerrieri-Gonzaga A; Caviglia S; Avino F; Cortesi L; Taverniti C; Pacquola MG; Falcini F; Gulisano M; Digennaro M; Cariello A; Cagossi K; Pinotti G; Lazzeroni M; Serrano D; Branchi D; Campora S; Petrera M; Buttiron Webber T; Boni L; Bonanni B
    J Clin Oncol; 2019 Jul; 37(19):1629-1637. PubMed ID: 30973790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal systemic therapy for premenopausal women with hormone receptor-positive breast cancer.
    Jankowitz RC; McGuire KP; Davidson NE
    Breast; 2013 Aug; 22 Suppl 2():S165-70. PubMed ID: 24074781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tamoxifen co-administration during controlled ovarian hyperstimulation for in vitro fertilization in breast cancer patients increases the safety of fertility-preservation treatment strategies.
    Meirow D; Raanani H; Maman E; Paluch-Shimon S; Shapira M; Cohen Y; Kuchuk I; Hourvitz A; Levron J; Mozer-Mendel M; Brengauz M; Biderman H; Manela D; Catane R; Dor J; Orvieto R; Kaufman B
    Fertil Steril; 2014 Aug; 102(2):488-495.e3. PubMed ID: 24934489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized trial of tamoxifen versus tamoxifen plus aminoglutethimide as adjuvant treatment in postmenopausal breast cancer patients with hormone receptor-positive disease: Austrian breast and colorectal cancer study group trial 6.
    Schmid M; Jakesz R; Samonigg H; Kubista E; Gnant M; Menzel C; Seifert M; Haider K; Taucher S; Mlineritsch B; Steindorfer P; Kwasny W; Stierer M; Tausch C; Fridrik M; Wette V; Steger G; Hausmaninger H
    J Clin Oncol; 2003 Mar; 21(6):984-90. PubMed ID: 12637461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized double-blind 2 x 2 trial of low-dose tamoxifen and fenretinide for breast cancer prevention in high-risk premenopausal women.
    Decensi A; Robertson C; Guerrieri-Gonzaga A; Serrano D; Cazzaniga M; Mora S; Gulisano M; Johansson H; Galimberti V; Cassano E; Moroni SM; Formelli F; Lien EA; Pelosi G; Johnson KA; Bonanni B
    J Clin Oncol; 2009 Aug; 27(23):3749-56. PubMed ID: 19597031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of tamoxifen therapy on fertility in breast cancer survivors.
    Shandley LM; Spencer JB; Fothergill A; Mertens AC; Manatunga A; Paplomata E; Howards PP
    Fertil Steril; 2017 Jan; 107(1):243-252.e5. PubMed ID: 27887709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Risk of endometrial hyperplasia and carcinoma in breast cancer patients receiving adjuvant tamoxifen].
    Semiglazov VF; Maksimov SIa; Bulgatova EA; Meshkova IE; Chepik OF; Berstein LM
    Vopr Onkol; 2003; 49(2):198-204. PubMed ID: 12785205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The Oxford meta-analysis of 2000: reflections and comments].
    Mustacchi G
    Tumori; 2005; 91(5):1-9. PubMed ID: 16459647
    [No Abstract]   [Full Text] [Related]  

  • 20. Ductal carcinoma in situ, complexities and challenges.
    Leonard GD; Swain SM
    J Natl Cancer Inst; 2004 Jun; 96(12):906-20. PubMed ID: 15199110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.